{
    "identity": "nprot-6771",
    "title": "Standard Protocols for Generation of Monocyte-derived Cell Types",
    "content": [
        {
            "header": "Introduction",
            "content": "This document describes standard research protocols used for generation of human monocyte-derived macrophages and DC in the Hutchinson work-group.\r\n\n\n\r\n\n\n**Abbreviations** \r\n\n\nMreg: Regulatory macrophage\r\n\n\nDPBS: Dulbecco\u2019s modified phosphate buffered saline\r\n\n\nM-CSF: Macrophage colony-stimulating factor\r\n\n\nFBS: Fetal bovine serum\r\n\n\nHABS: Human AB serum\r\n\n\nIFN-\u03b3: Interferon-gamma\r\n\n\nLFH: Laminar flow hood\r\n\n\nPR: Phenol Red\r\n\n\nCPDA: Citrate-Phosphate-Dextrose-Adenine solution\r\n\n\nLRS: Leucocyte Reduction System"
        },
        {
            "header": "Reagents",
            "content": "**General reagents**\r\n\n\n\r\n\n\nRPMI1640 without phenol red \\(BE12918F, Lonza-Biozym)\r\n\n\nGlutamax100X \\(35050038, Gibco-life)\r\n\n\nPen-Strep 100X \\(15140-122, Gibco-life)\r\n\n\nrhM-CSF \\(216-MC-025, R&D)\r\n\n\nrhIFN-\u03b3 \\(IF002, Millipore)\r\n\n\nCD14 microbeads \\(130-050-201, Miltenyi)\r\n\n\nAlbunorm 20% - Human Albumin \\(Octapharma)\r\n\n\nCitrate-phosphate-dextrose-adenine solution \\(C4431, Sigma)\r\n\n\nDulbecco\u2019s Phosphate Buffered Saline without Ca<sup>2+</sup> or Mg<sup>2+</sup> \\(D8537, Sigma)\r\n\n\nBiocoll Separating Solution \\(L6115, Millipore-Biochrom)\r\n\n\nHuman AB Serum \\(ZKT T\u00fcbingen)\r\n\n\nFBS \\(10270, Life/Gibco)\r\n\n\nX-VIVO 10 \\(BE04-380Q, Lonza)\r\n\n\nhrGM-CSF \\(300-03, Peprotech)\r\n\n\nhrTNF-\u03b1 \\(300-01A, Peprotech)\r\n\n\nhrIL-4 \\(200-04, Peprotech)\r\n\n\nLPS \\(L2018, Sigma)\r\n\n\nDexamethasone \\(D4902, Sigma)\r\n\n\n\r\n\n\n**Materials**\r\n\n\n\r\n\n\nStericup+ Steritop 250ml \\(SCGPU02RE, Millipore)\r\n\n\nQuadroMACS Separation Unit \\(130-090-976, Miltenyi)\r\n\n\nPre-separation Filters \\(130-041-407, Miltenyi)\r\n\n\nLS Columns \\(130-042-401, Miltenyi)\r\n\n\nSarstedt Cell+ 6-well plates \\(833.920.300, Sarstedt)"
        },
        {
            "header": "Procedure",
            "content": "**1.  PREPARATION OF REAGENTS**\r\n\n\n\r\n\n\n**1.1 Preparation and storage of rhM-CSF**\r\n\n\n1. In a 15 ml Falcon tube, prepare a 7.5% solution of human albumin in DPBS without Ca\n2+\nor Mg\n2+\n.\r\n  2. Remove vial of 25 \u00b5g rhM-CSF from -20\u00b0C storage. Allow 5 min to equilibrate to RT.\r\n  3. Transfer a total of 2.5 ml DBPS without Ca\n2+\nor Mg\n2+\ninto the rhM-CSF vial in fractions to dissolve and wash-out all protein from the vial.\r\n  4. Transfer 2.5 ml rhM-CSF solution into a 50 ml Falcon tube.\r\n  5. Add 38 \u00b5l of human albumin solution from step \\(1.1.1). Mix gently.\r\n  6. Make 125 \u00b5l aliquots \\(ie. for 50 ml medium) in Eppendorf cups.\r\n  7. Store at -20\u00b0C for up to 8 weeks.\r\n  \r\n\n\n**1.2 Preparation and storage of rhIFN-\u03b3**\r\n\n\n1. In a 15 ml Falcon tube, prepare a 7.5% solution of human albumin in DPBS without Ca\n2+\nor Mg\n2+\n.\r\n  2. Remove vial of 100 \u00b5g rhIFN-\u03b3 from -20\u00b0C storage. Allow 5 min to equilibrate to RT.\r\n  3. Transfer a total of 3.8 ml DBPS without Ca\n2+\nor Mg\n2+\ninto the rhIFN-\u03b3 vial in fractions to dissolve and wash-out all protein from the vial.\r\n  4. Transfer 3.8 ml rhIFN-\u03b3 solution into a 50 ml Falcon tube.\r\n  5. Add 200 \u00b5l of human albumin solution from step \\(1.1.1). Mix gently.\r\n  6. Make 100 \u00b5l aliquots \\(ie. for 50 ml medium) in Eppendorf cups.\r\n  7. Store at -20\u00b0C for up to 8 weeks.\r\n  \r\n\n\n**1.3 Heat inactivation and storage of human AB serum and FBS**\r\n\n\n1. Thaw 100 ml aliquot of serum at 4\u00b0C overnight.\r\n  2. Pre-heat waterbath to 56\u00b0C.\r\n  3. Submerse serum bottle in 56\u00b0C waterbath for 30 min.\r\n  4. Transfer serum bottle to ice. Leave for 30 mins to cool.\r\n  5. Transfer to LFH and decontaminate.\r\n  6. Make 5, 10 or 20 ml aliquots of serum in Falcon tubes.\r\n  7. Store aliquots at -20\u00b0C for up to 4 weeks.\r\n  \r\n\n\n**1.4 Preparation of MACS buffer**\r\n\n\nCPDA is used in preference to EDTA. Human albumin is used in preference to bovine albumin.\r\n\n\n1. In LFH, transfer 90 ml DPBS without Ca\n2+\nor Mg\n2+\ninto a 250 ml Stericup device using a serological pipette\r\n  2. Transfer 10 ml CPDA to Stericup\r\n  3. Transfer 2.5 ml 20% human serum albumin to Stericup\r\n  4. Filter mixture. Store at 4\u00b0C.\r\n  \r\n\n\n**1.5 Preparation of Mreg culture medium**\r\n\n\nProtocol to produce 100 ml medium. Scale as required.\r\n\n\n1. Assemble medium components in a 250 ml Stericup device in LFH.\r\n  2. Transfer 88 ml RPMI-1640 without PR into Stericup using serological pipette.\r\n  3. Transfer 1 ml of 200 mM GlutaMax into Stericup using serological pipette.\r\n  4. Transfer 1 ml 100 X Pen-Strep into Stericup using serological pipette.\r\n  5. Transfer 10 ml heat-inactivated HABS into Stericup using serological pipette.\r\n  6. Transfer 250 \u00b5l rhM-CSF \\(see 1.1) into Stericup using pipette.\r\n  7. Filter medium mixture. Medium must be used fresh.\r\n  \r\n\n\n\r\n\n\n**1.6 Preparation of FBS-containing culture medium**\r\n\n\nProtocol to produce 100 ml medium. Scale as required.\r\n\n\n1. Assemble medium components in a 250 ml Stericup device in LFH.\r\n  2. Transfer 88 ml RPMI-1640 without PR into Stericup using serological pipette.\r\n  3. Transfer 1 ml of 200 mM GlutaMax into Stericup using serological pipette.\r\n  4. Transfer 1 ml 100 X Pen-Strep into Stericup using serological pipette.\r\n  5. Transfer 10 ml heat-inactivated FBS into Stericup using serological pipette.\r\n  6. Transfer 250 \u00b5l rhM-CSF \\(see 1.1) into Stericup using pipette.\r\n  7. Filter medium mixture. Medium must be used fresh.\r\n  \r\n\n\n**2. STARTING MATERIAL** \r\n\n\n\r\n\n\n\r\n\n\n**2.1 Obtaining apheresate from LRS chamber**\r\n\n\n1. Decontaminate outside of LRS chamber using alcohol wipe. Transfer to LFH.\r\n  2. Hold the LRS chamber with the conical point downwards. Clamp the lower tube with sterile surgical forceps. \r\n  3. Cut the lower tube with sterile scissors below the clamp.\r\n  4. Cut the upper tube using sterile scissors. \r\n  5. Hold the LRS chamber over an open 50 ml Falcon tube and remove the clamp. \r\n  6. Allow the contents of the LRS chamber to run into the Falcon tube.\r\n  7. Perform automated cell count \\(differential count including monocytes).\r\n  8. Perform flow cytometry analyses \\(eg. CD14\n+\nmonocytes).\r\n  \r\n\n\n**2.2 Separation of PBMC by density gradient centrifugation**\r\n\n\nFicoll density gradient centrifugation is used to enrich PBMC prior to CD14 selection by MACS. This is necessary when working with apheresates from LRS chambers, buffy coats or whole blood, owing to their high content of neutrophils \\(which may be CD14\nlow\n) and erythrocytes. \r\n\n\n1. Dilute contents of LRS chamber 1:1 in sterile DBPS without Ca\n2+\nor Mg\n2+\nat RT.\r\n  2. Transfer 20 ml Ficoll solution at RT into a 50 ml Falcon tube.\r\n  3. Gently overlay diluted apheresate onto Ficoll using a serological pipette.\r\n  4. Place the layered columns into a swing-bucket centrifuge.\r\n  5. Centrifuge at RT for 25 min at 850 g with low acceleration and no brake.\r\n  6. Remove tubes from centrifuge. Decontaminate with alcohol wipes. Transfer to LFH.\r\n  7. Recover mononuclear cells from interface using a 10 ml serological pipette.\r\n  8. Transfer mononuclear cells to a 50 ml Falcon tube.\r\n  9. Resuspend cells in 50 ml DBPS without Ca\n2+\nor Mg\n2+\nat RT.\r\n  10. Pellet cells by centrifugation at 550 g for 10 mins at RT.\r\n  11. Aspirate supernatant using a 50 ml serological pipette.\r\n  12. Resuspend cells in 50 ml DBPS without Ca\n2+\nor Mg\n2+\nat RT.\r\n  13. Pellet cells by centrifugation at 300 g for 10 mins at RT.\r\n  14. Aspirate supernatant using a 50 ml serological pipette.\r\n  15. Resuspend cell pellet in 10 ml DPBS without Ca\n2+\nor Mg\n2+\nat RT.\r\n  16. Perform total and viable cell count using the Trypan Blue method.\r\n  17. Transfer required volume of cell suspension to a 50 ml Falcon tube.\r\n  \r\n\n\n**3.  MREG CULTURE **\r\n\n\n\r\n\n\n**3.1 Day_0 of culture: Isolation of monocytes \\(~90 minutes)**\r\n\n\n1. From the mononuclear cell preparation \\(see 2.2) take the required volume of PBMC.\r\n  2. Transfer to 50 ml Falcon. Pellet cells at 300 g for 6 min.\r\n  3. Resuspend cells in MACS buffer: 80 \u00b5l per 10\n7\ntotal cells.\r\n  4. Add 20 \u00b5l CD14 Microbeads per 10\n7\ntotal cells. Mix by gentle inversion.\r\n  5. Incubate for 15 min at 4\u00b0C \\(in fridge).\r\n  6. Add 15 ml MACS buffer to sample. Gentle mixing.\r\n  7. Centrifuge for 6 min at 300 g.\r\n  8. Place an LS column into magnet. Wash column with 3 ml MACS buffer.\r\n  9. Aspirate supernatant using serological pipette.\r\n  10. Resuspend cells in 1 ml MACS buffer.\r\n  11. Pass cell suspension through a pre-separation filter on column.\r\n  12. Wash column with 3 ml MACS buffer 3 times.\r\n  13. Remove column from magnet. Apply 5 ml MACS buffer.\r\n  14. Insert column plunger and eject column contents into a 50 ml Falcon.\r\n  15. Take aliquots of cells for \\(i) Trypan Blue count and \\(ii) CD14 analysis by flow cytometry.\r\n  \r\n\n\n**3.2 Day_0 of culture: Seeding of Mreg cultures: ~30 min**\r\n\n\n1. Take the required volume of CD14 monocyte suspension into a 50 ml Falcon.\r\n  2. Seed monocytes at 1 x 10\n6\nmonocytes/well \\(6-well plate).\r\n  3. Centrifuge monocyte suspension at 300 g for 10 min.\r\n  4. Aspirate supernatant using a serological pipette.\r\n  5. Resuspend cell pellet in Mreg medium at 1 x 10\n6\ncells/3 ml.\r\n  6. Transfer monocyte suspension into well palte: 3 ml cell suspension/well.\r\n  7. Place plates into 37\u00b0C 5%CO\n2\nincubator on horizontal shelves.\r\n  \r\n\n\n**3.3 Day_6 of culture: IFN-\u03b3 stimulation:  ~30 min**\r\n\n\n1. Remove culture plates from incubator. Transfer to LFH.\r\n  2. Thaw aliquots of rhIFN-\u03b3 as required.\r\n  3. Dilute 1000x rhIFN-\u03b3 solution by 1:5 in DPBS .\r\n  4. Apply IFN-\u03b3 to cultures at 25 ng/ml end concentration \\(ie. 15 \u03bcl into 3 ml well).\r\n  5. Gently mix by swirling.\r\n  6. Replace plates into incubator and incubate for a further 18 to 24 hours.\r\n  \r\n\n\n**3.4 Day_7 of culture: Cell harvest: ~40 min**\r\n\n\n1. Remove culture plates or flask from incubator. \r\n  2. Inspect culture plates or flasks using an inverted microscope. Assess morphology and density:\r\n  a. Cells should be mostly adherent. Cells should have a spreading morphology. Spiky cells forming clusters in suspension are an indication of a poor-quality culture.\r\n\n\nb. With experience it is possible to judge cell density. Look also for cell debris suggesting death of cells in culture.\r\n\n\n3. Transfer to LFH. Discard medium.\r\n  4. Wash with DPBS \\(1 ml/well or 5 ml/flask). Discard non-adherent cells.\r\n  5. Add DPBS \\(1 ml/well of 5 ml/flask)\r\n  6. Gentle scrape with a soft cell scrapper.\r\n  7. Transfer cell solution into a Falcon tube.\r\n  8. Centrifuge for 6 min at 300 g.\r\n  9. Aspirate supernatant. Resuspend cells in DPBS.\r\n  10. Count cells by Trypan Blue method.\r\n  11. Assess cell phenotype by flow cytometry.\r\n  \r\n\n\n**4. GENERATION OF OTHER MONOCYTE-DERIVED CELL TYPES**\r\n\n\n\r\n\n\n**4.1 Generation of monocyte-derived dendritic cells**\r\n\n\n1. Isolate  CD14\n+\nmonocytes as described in Section 2 and 3.1\r\n  2. Prepare DC medium: RPMI 1640 containing Pen-Strep, GlutaMAX, 5% HABS, 100 ng/ml rhGM-CSF, 100 ng/ml rhIL-4.\r\n  3. Resuspend  the required number of CD14\n+\nmonocytes in DC medium at \r\n  4. 1 x 10\n6\ncells/3 ml.\r\n  5. Seed monocytes at 1 x 10\n6\nmonocytes/well \\(6-well plate).\r\n  6. Place plates into 37\u00b0C 5%CO\n2\nincubator on horizontal shelves.\r\n  7. On day 5 harvest immature mo-DC by pipetting.\r\n  8. Transfer cells into a Falcon tube and centrifuge for 6 min at 300 g.\r\n  9. Resuspend pellet in X-VIVO 10 medium containing 2mM GlutaMAX and 100 ng/ml rhGM-CSF. \r\n  10. Replate immature DCs in 6-well plates at  1 x 10\n6\ncells/well.\r\n  11. For maturation add 50 ng/ml rhTNF-\u03b1 and culture for 2 more days.\r\n  12. Harvest by pipetting. Wash wells with PBS.\r\n  13. Transfer cell solution into a Falcon tube.\r\n  14. Centrifuge for 6 min at 300 g.\r\n  15. Aspirate supernatant. Resuspend cells in DPBS.\r\n  16. Count cells by Trypan Blue method.\r\n  17. Assess cell phenotype by flow cytometry.\r\n  \r\n\n\n**4.2      Generation of polarised macrophages**\r\n\n\n1. Isolate  CD14\n+\nmonocytes as described in Section  2 and 3.1.\r\n  2. Resuspend the necessary amount of monocytes in FBS-containing medium \\(Section 1.6) at 1 x 10\n6\ncells/3 ml.\r\n  3. Seed 1 x 10\n6\nmonocytes/well in 6-well.\r\n  4. On day 6 stimulate for 18-24h as follows:\r\n  - Resting M\u03c6 : no stimulation.\r\n\n\n- IFN-\u03b3-M\u03c6: 25 ng/mL rhIFN-\u03b3.\r\n\n\n- IFN-\u03b3+LPS M\u03c6: 25 ng/mL rhIFN-\u03b3 + 100 ng/ml LPS.\r\n\n\n- IL-4 M\u03c6: 20 ng/mL rhIL-4.\r\n\n\n- GC M\u03c6: 10\n-7\nM dexamethasone.\r\n\n\n5. On day 7 inspect culture plates using an inverted microscope. \r\n  6. Harvest cells by pipetting.\r\n  7. Add 1 ml DPBS per well.\r\n  8. Gentle scrape with a soft cell scrapper to harvest adherent cells.\r\n  9. Transfer cell solution into a Falcon tube.\r\n  10. Centrifuge for 6 min at 300 g.\r\n  11. Aspirate supernatant. Resuspend cells in DPBS.\r\n  12. Count cells by Trypan Blue method.\r\n  13. Assess cell phenotype by flow cytometry."
        },
        {
            "header": "References",
            "content": "1. Hutchinson J.A. _et al._ MITAP-compliant characterization of\r\n  human regulatory macrophages. Transpl Int. 30\\(8):765-775 \\(2017).\r\n\n\n\r\n\n\n2. Hutchinson J.A. _et al._ Cutting Edge: Immunological consequences and\r\n  trafficking of human regulatory macrophages administered to renal transplant\r\n\n\nrecipients. J Immunol. 1;187\\(5):2072-8 \\(2011)\r\n\n\n\r\n\n\n3. Hutchinson J.A. _et al._ Human regulatory\r\n  macrophages. Methods Mol Biol. 677:181-92 \\(2011)"
        }
    ],
    "attributes": {
        "acceptedTermsAndConditions": true,
        "allowDirectSubmit": true,
        "archivedVersions": [],
        "articleType": "Method Article",
        "associatedPublications": [],
        "authors": [
            {
                "id": 15673,
                "identity": "a16e1510-516f-11e9-9e20-12b504df345a",
                "order_by": 0,
                "name": "Paloma Riquelme",
                "email": "paloma.riquelme@klinik.uni-regensburg.de",
                "orcid": "",
                "institution": "Department of Surgery, University Hospital Regensburg",
                "correspondingAuthor": true,
                "prefix": "",
                "firstName": "Paloma",
                "middleName": "",
                "lastName": "Riquelme",
                "suffix": ""
            },
            {
                "id": 15674,
                "identity": "a16e1aa8-516f-11e9-9e20-12b504df345a",
                "order_by": 0,
                "name": "James A. Hutchinson",
                "email": "james.hutchinson@klinik.uni-regensburg.de",
                "orcid": "",
                "institution": "Department of Surgery, University Hospital Regensburg",
                "correspondingAuthor": true,
                "prefix": "",
                "firstName": "James",
                "middleName": "A.",
                "lastName": "Hutchinson",
                "suffix": ""
            }
        ],
        "badges": [],
        "createdAt": "2018-05-11 07:52:31",
        "currentVersionCode": 1,
        "declarations": "",
        "doi": "10.1038/protex.2018.065",
        "doiUrl": "https://doi.org/10.1038/protex.2018.065",
        "draftVersion": [],
        "editorialEvents": [],
        "editorialNote": "",
        "failedWorkflow": [],
        "files": [
            {
                "id": 13466045,
                "identity": "772709a6-0d08-426f-b315-d7b44f48d341",
                "added_by": "auto",
                "created_at": "2021-09-16 20:49:18",
                "extension": "pdf",
                "order_by": 0,
                "title": "",
                "display": "",
                "copyAsset": false,
                "role": "manuscript-pdf",
                "size": 142977,
                "visible": true,
                "origin": "",
                "legend": "",
                "description": "",
                "filename": "manuscript.pdf",
                "url": "https://assets.researchsquare.com/files/nprot-6771/v1/d9c45a69-4598-4e93-bb6a-ebe8385a3731.pdf"
            }
        ],
        "financialInterests": "The authors declare no competing financial interest.",
        "fulltextSource": "",
        "fullText": "",
        "funders": [],
        "hasOptedInToPreprint": true,
        "hasPassedJournalQc": "",
        "hideJournal": true,
        "highlight": "",
        "institution": "",
        "isAuthorSuppliedPdf": false,
        "isDeskRejected": "",
        "isHiddenFromSearch": false,
        "isInQc": false,
        "isInWorkflow": false,
        "journal": {
            "display": true,
            "email": "protocol.exchange@nature.com",
            "identity": "protocol-exchange",
            "isNatureJournal": false,
            "hasQc": false,
            "allowDirectSubmit": true,
            "externalIdentity": "",
            "sideBox": "",
            "submissionUrl": "https://protocolexchange.researchsquare.com/submission",
            "title": "Protocol Exchange",
            "twitterHandle": ""
        },
        "keywords": "Mreg, regulatory macrophage, monocyte, macrophage, moDC, macrophage polarization, PBMC",
        "license": {
            "name": "CC BY 4.0",
            "url": "https://creativecommons.org/licenses/by/4.0/"
        },
        "manuscriptAbstract": "This document describes standard research protocols used for generation of human monocyte-derived macrophages and DC in the Hutchinson work-group.",
        "manuscriptTitle": "Standard Protocols for Generation of Monocyte-derived Cell Types",
        "msid": "",
        "msnumber": "",
        "nonDraftVersions": [
            {
                "code": 1,
                "date": "2018-07-11 05:39:04",
                "doi": "10.1038/protex.2018.065",
                "editorialEvents": [
                    {
                        "type": "communityComments",
                        "content": 1
                    }
                ],
                "status": "published",
                "journal": {
                    "display": true,
                    "email": "info@researchsquare.com",
                    "identity": "researchsquare",
                    "isNatureJournal": false,
                    "hasQc": true,
                    "allowDirectSubmit": true,
                    "externalIdentity": "",
                    "sideBox": "",
                    "submissionUrl": "/submission",
                    "title": "Research Square",
                    "twitterHandle": "researchsquare"
                }
            }
        ],
        "origin": "",
        "ownerIdentity": "a16d1954-516f-11e9-9e20-12b504df345a",
        "owner": [],
        "postedDate": "July 11th, 2018",
        "published": true,
        "revision": "",
        "status": "posted",
        "subjectAreas": [
            {
                "id": 4261,
                "name": "Biological techniques"
            }
        ],
        "tags": [],
        "versionOfRecord": [],
        "versionCreatedAt": "2018-07-11 05:39:04",
        "video": "",
        "vorDoi": "",
        "vorDoiUrl": "",
        "workflowStages": []
    }
}